Terms: = Lung cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Diagnosis
32 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the lung.
Buium C; Negru S; Ionescu DN; Dediu M
Curr Oncol; 2023 Jul; 30(8):7218-7228. PubMed ID: 37623004
[TBL] [Abstract] [Full Text] [Related]
3. Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline
Yoshida H; Hiranuma K; Nakahara M; Kobayashi-Kato M; Tanase Y; Uno M; Shiraishi K; Ishikawa M; Kato T
Int J Surg Pathol; 2024 Apr; 32(2):394-400. PubMed ID: 37226494
[TBL] [Abstract] [Full Text] [Related]
4. Tumor loss-of-function mutations in stk11/lkb1 induce cachexia.
Iyengar P; Gandhi AY; Granados J; Guo T; Gupta A; Yu J; Llano EM; Zhang F; Gao A; Kandathil A; Williams D; Gao B; Girard L; Malladi VS; Shelton JM; Evers BM; Hannan R; Ahn C; Minna JD; Infante RE
JCI Insight; 2023 Apr; 8(8):. PubMed ID: 37092555
[TBL] [Abstract] [Full Text] [Related]
5. A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell lung cancer.
Iams WT; Balbach ML; Phillips S; Sacher A; Bestvina C; Velcheti V; Wang X; Marmarelis ME; Sethakorn N; Leal T; Sackstein PE; Kim C; Robinson MA; Mehta K; Hsu R; Nieva J; Patil T; Camidge DR
Clin Lung Cancer; 2023 May; 24(3):228-234. PubMed ID: 36841727
[TBL] [Abstract] [Full Text] [Related]
6. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell lung cancer Reveals
De B; Farooqi AS; Mitchell KG; Ludmir EB; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee JJ; Swisher SG; Gibbons DL; Zhang J; Le X; Elamin YY; Gomez DR; Ning MS; Lin SH; Liao Z; Chang JY; Vaporciyan AA; Heymach JV; Antonoff MB; Gandhi SJ
JCO Precis Oncol; 2023 Jan; 7():e2200540. PubMed ID: 36716413
[TBL] [Abstract] [Full Text] [Related]
7. Clinical impact of stk11 mutation in advanced-stage non-small cell lung cancer.
Rosellini P; Amintas S; Caumont C; Veillon R; Galland-Girodet S; Cuguillière A; Nguyen L; Domblides C; Gouverneur A; Merlio JP; Bezin J; Girodet PO
Eur J Cancer; 2022 Sep; 172():85-95. PubMed ID: 35759814
[TBL] [Abstract] [Full Text] [Related]
8. lung cancer as a predominant feature in a patient with Peutz-Jeghers syndrome: Case report.
Fostira F; Fountzilas E; Papadopoulou K; Karaiskos T; Mpatsi O; Pastelli N; Mountzios G; Konstantopoulou I; Fountzilas G
Thorac Cancer; 2022 Jun; 13(12):1862-1865. PubMed ID: 35543335
[TBL] [Abstract] [Full Text] [Related]
9. Perspectives and Issues in the Assessment of
Armon S; Hofman P; Ilié M
Cells; 2021 Jul; 10(8):. PubMed ID: 34440689
[TBL] [Abstract] [Full Text] [Related]
10. Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA).
Wislez M; Domblides C; Greillier L; Mazières J; Monnet I; Kiakouama-Maleka L; Quantin X; Spano JP; Ricordel C; Fraisse P; Janicot H; Audigier-Valette C; Amour E; Langlais A; Rabbe N; Makinson A; Cadranel J; Laurent-Puig P; Lavolé A; Blons H
Lung Cancer; 2021 Jul; 157():124-130. PubMed ID: 34016488
[TBL] [Abstract] [Full Text] [Related]
11. stk11 alterations in the pan-cancer setting: prognostic and therapeutic implications.
Krishnamurthy N; Goodman AM; Barkauskas DA; Kurzrock R
Eur J Cancer; 2021 May; 148():215-229. PubMed ID: 33744718
[TBL] [Abstract] [Full Text] [Related]
12. Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell lung cancer.
Arbour KC; Rizvi H; Plodkowski AJ; Hellmann MD; Knezevic A; Heller G; Yu HA; Ladanyi M; Kris MG; Arcila ME; Rudin CM; Lito P; Riely GJ
Clin Cancer Res; 2021 Apr; 27(8):2209-2215. PubMed ID: 33558425
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Shang Y; Li X; Liu W; Shi X; Yuan S; Huo R; Fang G; Han X; Zhang J; Wang K; Dou Z; Zhang Y; Zang A; Zhang L
Sci Rep; 2020 Nov; 10(1):20243. PubMed ID: 33219256
[TBL] [Abstract] [Full Text] [Related]
14. Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and stk11: A case report.
Fricke J; Mambetsariev I; Pharaon R; Subbiah S; Rajurkar S; Salgia R
Medicine (Baltimore); 2020 Nov; 99(46):e22323. PubMed ID: 33181636
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer.
Lamberti G; Spurr LF; Li Y; Ricciuti B; Recondo G; Umeton R; Nishino M; Sholl LM; Meyerson ML; Cherniack AD; Awad MM
Ann Oncol; 2020 Jun; 31(6):807-814. PubMed ID: 32171752
[TBL] [Abstract] [Full Text] [Related]
16. An occult urothelial carcinoma with wide multiorgan metastases and its genetic alteration profiling: Case report and literature review.
Bu K; Shi Z; Lu Y; Zhao J; Li B
Medicine (Baltimore); 2019 Apr; 98(16):e15245. PubMed ID: 31008958
[TBL] [Abstract] [Full Text] [Related]
17. Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease.
Philley JV; Hertweck KL; Kannan A; Brown-Elliott BA; Wallace RJ; Kurdowska A; Ndetan H; Singh KP; Miller EJ; Griffith DE; Dasgupta S
Sci Rep; 2018 Jul; 8(1):11336. PubMed ID: 30054559
[TBL] [Abstract] [Full Text] [Related]
18. KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.
Mehrad M; Roy S; LaFramboise WA; Petrosko P; Miller C; Incharoen P; Dacic S
Histopathology; 2018 Aug; 73(2):207-214. PubMed ID: 29489023
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.
Derks JL; Leblay N; Thunnissen E; van Suylen RJ; den Bakker M; Groen HJM; Smit EF; Damhuis R; van den Broek EC; Charbrier A; Foll M; McKay JD; Fernandez-Cuesta L; Speel EM; Dingemans AC;
Clin Cancer Res; 2018 Jan; 24(1):33-42. PubMed ID: 29066508
[No Abstract] [Full Text] [Related]
20. Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Rekhtman N; Pietanza CM; Sabari J; Montecalvo J; Wang H; Habeeb O; Kadota K; Adusumilli P; Rudin CM; Ladanyi M; Travis WD; Joubert P
Mod Pathol; 2018 Jan; 31(1):111-121. PubMed ID: 28884744
[TBL] [Abstract] [Full Text] [Related]
[Next]
